pubrio
Medicalgorithmics S.A. logo

Medicalgorithmics S.A.

Public
medicalgorithmics.com
軟件開發200+ employeesFounded 2005🇵🇱 波蘭

Medicalgorithmics is a medical technology company specialized in AI-powered and noninvasive solutions for cardiac arrhythmia. Over the past 15 years, we have transformed into a global provider of cutting-edge solutions that help improve the health of patients around the world. We have put science and innovation at the heart of our work. We are closely cooperating with healthcare professionals to reduce costs, streamline clinical workflows and most importantly improve the quality of patient care. We are striving to design AI algorithms that can accurately detect and diagnose diseases at an early stage, increasing the chances of a successful treatment. Our innovative portfolio spans across software, artificial intelligence and cloud based solutions for healthcare systems, physicians and medical technology companies. Our flagship products include PocketECG system, FDA-approved TechBot and DeepRhythm software platforms for cardiac arrhythmia. We invented noninvasive AI-powered VCAST (Virtual Cardiac Stress Test) technology, which we believe can revolutionize the diagnosis and treatment of coronary artery disease in the years ahead. Medicalgorithmics has been listed on the Warsaw Stock Exchange since 2014.

成立年份
2005
員工
200+
行業
軟件開發
公司類型
Public Company
總部
🇵🇱Warszawa, - (+2)
專長
資訊科技與服務醫療器材軟件開發醫療保健人工智能

擴張情報

全新 · Pubrio 獨家

我們正在追蹤 Medicalgorithmics S.A. 的市場擴張

全球擴張

即時
階段
探索中投入中進入中營運中

活動脈搏

全新 市場推廣與公關 活動 — 剛出現 34 個新訊號。

過去 90 日
招聘
0
無活動
市場推廣與公關
34新增
廣告
產品與技術
0
無活動
+2個類別已鎖定
已顯示 5 個中的 3 個
值得了解

關於 Medicalgorithmics S.A. 的常見問題

關於 Medicalgorithmics S.A. 業務、市場及增長訊號的快速解答。

Medicalgorithmics is a medical technology company specialized in AI-powered and noninvasive solutions for cardiac arrhythmia. Over the past 15 years, we have transformed into a global provider of cutting-edge solutions that help improve the health of patients around the world. We have put science and innovation at the heart of our work. We are closely cooperating with healthcare professionals to reduce costs, streamline clinical workflows and most importantly improve the quality of patient care. We are striving to design AI algorithms that can accurately detect and diagnose diseases at an early stage, increasing the chances of a successful treatment. Our innovative portfolio spans across software, artificial intelligence and cloud based solutions for healthcare systems, physicians and medical technology companies. Our flagship products include PocketECG system, FDA-approved TechBot and DeepRhythm software platforms for cardiac arrhythmia. We invented noninvasive AI-powered VCAST (Virtual Cardiac Stress Test) technology, which we believe can revolutionize the diagnosis and treatment of coronary artery disease in the years ahead. Medicalgorithmics has been listed on the Warsaw Stock Exchange since 2014.

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。